| 12371501 |
Extended local release of anti-CSFR1 antibodies |
Chung-Chiang Hsu, Kirk W. Johnson |
2025-07-29 |
|
| 12178915 |
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies |
Chung-Chiang Hsu, Aihua Zhu, Kirk W. Johnson, Michael Huang |
2024-12-31 |
|
| 12049495 |
Stable protein solution formulation containing high concentration of an anti-VEGF antibody |
Huixiang Zhang, Charles Boring, Alok K. Kulshreshtha, Yuhong Zeng, Li Wan |
2024-07-30 |
$30,611,000 |
| 11752096 |
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumors |
Kirk W. Johnson, Michael Huang, Chung-Chiang Hsu |
2023-09-12 |
|
| 11427641 |
Extended local release of anti-CSFR1 antibodies |
Chung-Chiang Hsu, Kirk W. Johnson |
2022-08-30 |
|
| 11419822 |
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies |
Chung-Chiang Hsu, Aihua Zhu, Kirk W. Johnson, Michael Huang |
2022-08-23 |
|
| 10689438 |
Stable protein solution formulation containing high concentration of an anti-VEGF antibody |
Huixiang Zhang, Charles Boring, Alok K. Kulshreshtha, Yuhong Zeng, Li Wan |
2020-06-23 |
$31,603,000 |
| 9901640 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2018-02-27 |
$28,837,000 |
| 9533046 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2017-01-03 |
$13,464,000 |
| 9533053 |
High concentration olopatadine ophthalmic composition |
Daniel A. Gamache, Malay Ghosh, Francisco Javier Galan, Nuria Carreras Perdiguer, Onkar N. Singh |
2017-01-03 |
|
| 9504691 |
Finafloxacin suspension compositions |
Brent G. Boudreaux, Mark J. Bridle, Bryan H. Huynh, Malay Ghosh, Masood A. Chowhan +1 more |
2016-11-29 |
|
| 9463246 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2016-10-11 |
$18,138,000 |
| 9089607 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2015-07-28 |
$14,110,000 |
| 9089608 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2015-07-28 |
$14,110,000 |
| 8895051 |
Flavoring systems for pharmaceutical compositions and methods of making such compositions |
Donald P. Gauwitz, Dilip Kaul, John M. Lipari, Soumojeet Ghosh, Kennan C. Marsh +2 more |
2014-11-25 |
|
| 8791154 |
High concentration olopatadine ophthalmic composition |
Daniel A. Gamache, Malay Ghosh, Francisco Javier Galan, Nuria Carreras Perdiguer, Onkar N. Singh |
2014-07-29 |
|
| 8691878 |
Solid pharmaceutical dosage form |
Jeorg Rosenberg, Ulrich Reinhold, Bernd Liepold, Gunther Berndl, Joerg Breitenbach +1 more |
2014-04-08 |
$56,269,000 |
| 8557283 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2013-10-15 |
$13,213,000 |
| 8501219 |
Flavoring systems for pharmaceutical compositions and methods of making such compositions |
Donald P. Gauwitz, Dilip Kaul, John M. Lipari, Soumojeet Ghosh, Kennan C. Marsh +2 more |
2013-08-06 |
$106,821,000 |
| 8486983 |
Self-emulsifying formulations of CETP inhibitors |
Agam R. Sheth, Bhagwant Rege, Soumojeet Ghosh, Maria T. Cruanes, Craig McKelvey |
2013-07-16 |
$58,549,000 |
| 8454998 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2013-06-04 |
$13,819,000 |
| 8414921 |
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
Ashkan Kamali, Kyle A. Fliszar, Soumojeet Ghosh, Monica Tijerina |
2013-04-09 |
$69,688,000 |
| 8399015 |
Solid pharmaceutical dosage form |
Joerg Rosenberg, Ulrich Reinhold, Bernd Liepold, Gunther Berndl, Joerg Breitenbach +1 more |
2013-03-19 |
$189,338,000 |
| 8377474 |
Controlled release formulations of levodopa and uses thereof |
Ann Hsu, Jim H. Kou |
2013-02-19 |
$10,710,000 |
| 8377952 |
Solid pharmaceutical dosage formulation |
Joerg Rosenberg, Ulrich Reinhold, Bernd Liepold, Gunther Berndl, Jorg Breitenbach +1 more |
2013-02-19 |
$8,193,000 |
